With radiotherapy en vogue, Belgian startup nabs nearly $42M in Series A funding
Interest in targeted radiation treatments was buoyed last month with Novartis’ $NVS $2.1 billion bet on Endocyte that put the spotlight on a decades …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.